Mechanism of action: Ethosuximide balliculeVisual mnemonic: Ethosuximide mascot “Zorro’s Ethics suck!” Child with petit mal seizure (approved for age 3+) Drug of choice for absence seizures
What it isT-type calcium-channel blocker in thalamic neurons; absence seizures.
Why this oneFirst-line for childhood absence epilepsy and preserves attention better than valproate.
What limits itDoes not cover tonic-clonic seizures; GI intolerance is common, and rare blood dyscrasias require counts.
Pearls
Valproate instead when tonic-clonic seizures coexist.
Hiccups, headache and behavioral change; psychosis reported.
Rare SJS, DRESS and drug-induced lupus.
Molecular structure: Ethosuximide
Ethosuximide prescription history
Animated chart of estimated U.S. prescriptions per year, Antiseizure meds (1869–2026). Ethosuximide enters in 1960 (estimated).
FDA-approved for
absence seizures (~1960)
Principal riskIt does not cover tonic-clonic seizures; blood dyscrasias